RNA Interference
Companies: n-Lorem (charitable antisense therapy for rare diseases). Avidity Biosciences (acquired by Novartis) (Antibody Oligonucleotide Conjugates (AOC™) platform) Introduction: RNA interference (RNAi) is an endogenous cellular process in which double-stranded…